Su CTIC c'è fermento.......ho preso un po di roba sui 4.035.......verso le 13 potrebbero venire benone....spero...
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Mon May 14, 3:01 AM
Email Story IM Story Printable View
SEATTLE, May 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq; MTAX: CTIC) today announced the management team for its recently- formed subsidiary Aequus BioPharma, Inc. Carl J. March, Ph.D., MBA, a former Senior Vice President at Immunex has been chosen to lead the new company as President and CEO. Stewart D. Chipman, Ph.D., Vice President of Research at CTI and former Director of Biomolecular Screening at Immunex, who was a co- inventor of the technology and managed the team that advanced its development through an initial proof of concept stage, will serve as Executive Vice President and Chief Scientific Officer. David Cosman, Ph.D., former Distinguished Fellow and Research Director at Amgen and Vice President of Molecular Biology at Immunex, will join the Company's Board of Directors.